Sumatriptan Injection, Solution
Product Images NDC 70069-804

5 FDA label images from Somerset Therapeutics, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 70069-804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1 Label)

Carton1 (Carton1 Label)
Packaging label for Sumatriptan Injection USP, 6 mg/0.5 mL solution for subcutaneous injection, presented as a single-dose vial. The label includes the NDC 70069-804-01, manufacturer Somerset Therapeutics LLC, and directions to protect from light and store between 2° to 30°C. It also notes the product is sterile, nonpyrogenic, and includes instructions for pharmacists to dispense the patient information leaflet.*
FDA Label Image

Carton5 (Carton5 Label)

Carton5 (Carton5 Label)
Packaging label for Sumatriptan Injection USP 6 mg/0.5 mL, a subcutaneous injection solution. The label shows the product is supplied in 5 x 0.5 mL single-dose vials and is manufactured by Somerset Therapeutics LLC. The label includes dosage information and storage instructions as well as a barcode.*
FDA Label Image

Vial-label (Label Vial)

Vial-label (Label Vial)
Label for Sumatriptan Injection USP 6 mg/0.5 mL, a subcutaneous injection solution presented in a 0.5 mL single-dose vial. The label includes dosing strength, barcodes, and manufacturer information: Somerset Therapeutics, LLC, Hollywood, FL. It contains instructions to protect from light and to discard unused portions.*
FDA Label Image

Sumatriptan-image01 (Sumatriptan Image01)

Sumatriptan-image01 (Sumatriptan Image01)
Chemical structure diagram of sumatriptan, showing its indole-based molecular framework with side chains including a sulfonamide group and a diethylaminoethyl group, alongside an indication of a carboxylic acid moiety.*
FDA Label Image

Image2 (Sumatriptan Image02)

Image2 (Sumatriptan Image02)
A line graph depicting the estimated percentage of patients with relief over time (minutes) comparing Sumatriptan and Placebo groups. The x-axis shows time in minutes up to 25, and the y-axis shows the estimated percentage of patients with relief from 0 to 100%. Two data sets are shown: Placebo (N=127) with lower relief percentages and Sumatriptan (N=131) with higher relief percentages over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.